BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35181392)

  • 1. Specific effects of somatic GATA2 zinc finger mutations on erythroid differentiation.
    Redondo Monte E; Leubolt G; Windisch R; Kerbs P; Dutta S; Landspersky T; Istvánffy R; Oostendorp RAJ; Chen-Wichmann L; Herold T; Cusan M; Schotta G; Wichmann C; Greif PA
    Exp Hematol; 2022 Apr; 108():26-35. PubMed ID: 35181392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia.
    Tien FM; Hou HA; Tsai CH; Tang JL; Chiu YC; Chen CY; Kuo YY; Tseng MH; Peng YL; Liu MC; Liu CW; Liao XW; Lin LI; Lin CT; Wu SJ; Ko BS; Hsu SC; Huang SY; Yao M; Chou WC; Tien HF
    Blood Cancer J; 2018 Aug; 8(9):87. PubMed ID: 30190467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia.
    Ping N; Sun A; Song Y; Wang Q; Yin J; Cheng W; Xu Y; Wen L; Yao H; Ma L; Qiu H; Ruan C; Wu D; Chen S
    Leukemia; 2017 Jan; 31(1):195-202. PubMed ID: 27389056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia.
    Greif PA; Dufour A; Konstandin NP; Ksienzyk B; Zellmeier E; Tizazu B; Sturm J; Benthaus T; Herold T; Yaghmaie M; Dörge P; Hopfner KP; Hauser A; Graf A; Krebs S; Blum H; Kakadia PM; Schneider S; Hoster E; Schneider F; Stanulla M; Braess J; Sauerland MC; Berdel WE; Büchner T; Woermann BJ; Hiddemann W; Spiekermann K; Bohlander SK
    Blood; 2012 Jul; 120(2):395-403. PubMed ID: 22649106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution.
    Hou HA; Lin YC; Kuo YY; Chou WC; Lin CC; Liu CY; Chen CY; Lin LI; Tseng MH; Huang CF; Chiang YC; Liu MC; Liu CW; Tang JL; Yao M; Huang SY; Ko BS; Hsu SC; Wu SJ; Tsay W; Chen YC; Tien HF
    Ann Hematol; 2015 Feb; 94(2):211-21. PubMed ID: 25241285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gata2-L359V impairs primitive and definitive hematopoiesis and blocks cell differentiation in murine chronic myelogenous leukemia model.
    Fu YK; Tan Y; Wu B; Dai YT; Xu XG; Pan MM; Chen ZW; Qiao N; Wu J; Jiang L; Lu J; Chen B; Rein A; Izraeli S; Sun XJ; Huang JY; Huang QH; Chen Z; Chen SJ
    Cell Death Dis; 2021 Jun; 12(6):568. PubMed ID: 34078881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C/EBPα and GATA-2 Mutations Induce Bilineage Acute Erythroid Leukemia through Transformation of a Neomorphic Neutrophil-Erythroid Progenitor.
    Di Genua C; Valletta S; Buono M; Stoilova B; Sweeney C; Rodriguez-Meira A; Grover A; Drissen R; Meng Y; Beveridge R; Aboukhalil Z; Karamitros D; Belderbos ME; Bystrykh L; Thongjuea S; Vyas P; Nerlov C
    Cancer Cell; 2020 May; 37(5):690-704.e8. PubMed ID: 32330454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukemia mutations corrupt but do not abrogate GATA-2 function.
    Katsumura KR; Mehta C; Hewitt KJ; Soukup AA; Fraga de Andrade I; Ranheim EA; Johnson KD; Bresnick EH
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):E10109-E10118. PubMed ID: 30301799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes.
    Chong CE; Venugopal P; Stokes PH; Lee YK; Brautigan PJ; Yeung DTO; Babic M; Engler GA; Lane SW; Klingler-Hoffmann M; Matthews JM; D'Andrea RJ; Brown AL; Hahn CN; Scott HS
    Leukemia; 2018 Jan; 32(1):194-202. PubMed ID: 28642594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GATA2 mutations in myeloid malignancies: Two zinc fingers in many pies.
    Leubolt G; Redondo Monte E; Greif PA
    IUBMB Life; 2020 Jan; 72(1):151-158. PubMed ID: 31785092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia.
    Zhang SJ; Ma LY; Huang QH; Li G; Gu BW; Gao XD; Shi JY; Wang YY; Gao L; Cai X; Ren RB; Zhu J; Chen Z; Chen SJ
    Proc Natl Acad Sci U S A; 2008 Feb; 105(6):2076-81. PubMed ID: 18250304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GATA2 zinc finger 2 mutation found in acute myeloid leukemia impairs myeloid differentiation.
    Niimi K; Kiyoi H; Ishikawa Y; Hayakawa F; Kurahashi S; Kihara R; Tomita A; Naoe T
    Leuk Res Rep; 2013; 2(1):21-5. PubMed ID: 24371770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative and qualitative impairments in GATA2 and myeloid neoplasms.
    Shimizu R; Yamamoto M
    IUBMB Life; 2020 Jan; 72(1):142-150. PubMed ID: 31675473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of protein structure and the role of individual fingers in zinc finger protein-DNA recognition: a molecular dynamics simulation study and free energy calculations.
    Hamed MY
    J Comput Aided Mol Des; 2018 Jun; 32(6):657-669. PubMed ID: 29725908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and characterization of the GATA1 cofactor human FOG1 and assessment of its binding to GATA1 proteins carrying D218 substitutions.
    Freson K; Thys C; Wittewrongel C; Vermylen J; Hoylaerts MF; Van Geet C
    Hum Genet; 2003 Jan; 112(1):42-9. PubMed ID: 12483298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic genetic alterations predict hematological progression in GATA2 deficiency.
    Largeaud L; Collin M; Monselet N; Vergez F; Fregona V; Larcher L; Hirsch P; Duployez N; Bidet A; Luquet I; Bustamante J; Dufrechou S; Prade N; Nolla M; Hamelle C; Tavitian S; Habib C; Meynier M; Bellanne-Chantelot C; Donadieu J; De Fontbrune FS; Fieschi C; Ferster A; Delhommeau F; Delabesse E; Pasquet M
    Haematologica; 2023 Jun; 108(6):1515-1529. PubMed ID: 36727400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA2 deficiency and related myeloid neoplasms.
    Wlodarski MW; Collin M; Horwitz MS
    Semin Hematol; 2017 Apr; 54(2):81-86. PubMed ID: 28637621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid lineage differentiation.
    Moriguchi T; Yamamoto M
    Int J Hematol; 2014 Nov; 100(5):417-24. PubMed ID: 24638828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure of a Zap1 zinc-responsive domain provides insights into metalloregulatory transcriptional repression in Saccharomyces cerevisiae.
    Wang Z; Feng LS; Matskevich V; Venkataraman K; Parasuram P; Laity JH
    J Mol Biol; 2006 Apr; 357(4):1167-83. PubMed ID: 16483601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of GATA factor expression is distinct between erythroid and mast cell lineages.
    Ohmori S; Takai J; Ishijima Y; Suzuki M; Moriguchi T; Philipsen S; Yamamoto M; Ohneda K
    Mol Cell Biol; 2012 Dec; 32(23):4742-55. PubMed ID: 22988301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.